be_ixf;ym_202605 d_27; ct_50
NASDAQ:GRAB charts & data provided by TradingView

Latest Insights on GRAB

Shake It Up With This Leading ETF December 8, 2021 by Clint Lee Big Picture. Big Profits., Economy, Investment Opportunities "A what?" That’s the response from my 10-year-old when I asked if he’s ever played with an Etch A Sketch. As he toyed with his iPad, I told him it’s the original tablet that you simply shook to start over. Which makes it the perfect tablet for writing a script for this stock market — shake it and start over! It sure would be nice if a script like that did exist. Some have even tried to assume that the economic cycle follows some nice plot with stock market sectors responding on cue. But it’s never that simple...
UOA: These Bears Are Betting $10 Million Against a Recovery UOA: These Bears Are Betting $10 Million Against a Recovery December 6, 2021 by Chad Shoop Trading Strategies, True Options Masters, Unusual Options Activity In today's Unusual Options Activity, Chad Shoop spotted nearly $10 million in bearish bets as headlines continue to push stocks lower...
Rush for a Change of Atmosphere Meme EVs Tangled Tax Weave, Power Grids Be Jammin’ & Volatility Be Slammin’ December 3, 2021 by Joseph Hargett Great Stuff Friday Feedback: The “Spirit Of Great Stuff” Edition End the week with a friendly voice, a companion so obtrusive. Plays that song that’s so elusive, and the magic lyrics make your portfolio move. Off on your way, hit the open market, there is Great Stuff at your fingers. Mr. Great Stuff ever lingers, undemanding contact […]
Jurassic Park Nobody Cares Omicron Variant Meme On DoorDashers, On Box’ers, On Chipmakers … C’mon, Becto! December 1, 2021 by Joseph Hargett Great Stuff A Little Dash’ll Do Ya? It’s been, what … less than a week since COVID-19 Omicron debuted, and I’m already tired of it. And I’m sure you’re tired of hearing about Omicron as well, Great Ones. Wall Street is also tired of it, apparently, as stocks attempted to push sharply higher today. But, as resilient […]
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 by Ted Bauman Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This